Marsh McLennan (MRSH)
NYSE: MRSH · Insurance Brokers · New York, NY
Our rating: Positive
Positive reaffirmed at $188.35, moderate conviction, October 16, 2026.
Breaks if: The Positive call depends on top-line momentum and capital returns holding near current levels. It is invalidated if revenue growth reported in the next two consecutive 10-Q filings falls below 6% — roughly half the current 10.3% pace — because at 5.87× book there is no valuation cushion to absorb a deceleration of that size without a meaningful re-rating. Separately, if ROE slips below 22% in the next annual filing, the premium over book becomes structurally harder to defend and the case moves to Neutral.
Key figures
| Market value | $98.1B |
|---|---|
| Revenue, last 12 months | $28.5B |
| Net income, last 12 months | $4.0B |
| Free cash flow, last 12 months | $4.2B |
| Price to earnings | 24.3× |
| Free cash flow yield | 4.2% |
| Dividend yield | 1.8% |
| Operating margin | 21.4% |
| Return on equity | 26.7% |
| Beta to the S&P 500 | 0.15 |
| Volatility, annualized | 21.9% |
Reported quarters
| Quarter ending | Revenue | Year on year | Earnings per share | Free cash flow |
|---|---|---|---|---|
| September 30, 2026 | $6.9B | 8.1% | $1.69 | $1.4B |
| June 30, 2026 | $7.4B | 6.2% | $2.63 | $1.5B |
| March 31, 2026 | $7.6B | 7.6% | $2.36 | −$750M |
| December 31, 2025 | $6.6B | 8.7% | $1.68 | $2.1B |
| September 30, 2025 | $6.4B | 11.5% | $1.51 | $2.0B |
| June 30, 2025 | $7.0B | 12.1% | $2.45 | $1.6B |
| March 31, 2025 | $7.1B | 9.1% | $2.79 | −$677M |
| December 31, 2024 | $6.1B | 9.2% | $1.59 | $1.9B |
Three-model forecasts for the next quarter
Written November 21, 2026, before the report. Each settles from the SEC filing.
- Revenue for the quarter is at least $7.10B: Claude 72%, Gemini 90%, Mistral 55%
- Diluted earnings per share are at least $1.68: Claude 68%, Gemini 88%, Mistral 70%
- Free cash flow for the quarter is at least $2.06B: Claude 45%, Gemini 45%, Mistral 45%
14 ledger entries and 41 corporate events on record. Share price as of November 20, 2026. Research and education only. Not investment advice. Stoquity does not manage money or know your circumstances. Ratings, forecasts and lists are produced by software and AI models and can be wrong. Performance figures are hypothetical, measured on paper against a benchmark, and say nothing certain about the future.